Glenmark Pharmaceuticals’ arm recalls over 32,000 bottles of Zonisamide capsules

16 May 2022 Evaluate

Glenmark Pharmaceuticals’ subsidiary company -- Glenmark Pharmaceuticals Inc is recalling over 32,000 bottles of Zonisamide capsules in the US market. The medication is used to treat and prevent epilepsy. As per US Food and Drug Administration (USFDA), the US firm, a unit of Mumbai-based Glenmark Pharmaceuticals, is recalling the affected lot due to ‘CGMP deviations’.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1698.00 27.10 (1.62%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.